Atlas Trials

B Cell Malignancies

36 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch B Cell Malignancies

RecordFirmDate
Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies (NCT05275504)TransThera Sciences (Nanjing), Inc.2022-06-01
Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies (NCT04551963)BeiGene2020-11-15
Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465) (NCT04509700)Incyte Corporation2020-08-03
Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies (NCT04170283)BeiGene2020-01-16
Clinical Study of ET019002-T Cell Therapy for Refractory/Relapsed B-Cell Malignancies (NCT03642496)First Affiliated Hospital Xi'an Jiaotong University2018-08-19
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) (NCT02327078)Incyte Corporation2014-11-26
Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies (NCT02343120)BeiGene2014-09-04
Study of INCB040093 in Subjects With Previously Treated B-Cell Malignancies (NCT01905813)Incyte Corporation2013-06-30
Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma (NCT01775631)Bristol-Myers Squibb2013-03-01
A Clinical Study Using MEDI-551 in Adult Participants With Relapsed or Refractory Advanced B-Cell Malignancies (NCT00983619)MedImmune LLC2010-04-16
A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation (NCT00672152)Michael Morse, MD2007-06-01

Track B Cell Malignancies automatically

Every clearance here is in the API, with alerts when new ones post.